Medical Device Market & Industry Briefs, June/July 2012
Brief summaries of recent medtech market and industry developments. This month we cover recent developments in renal denervation, which may be the next blockbuster device market, MindRay’s acquisition of China’s Wuhan Dragonbio Surgical Implant Co., and the GAO’s report on implantable device use by Medicare beneficiaries.
You may also be interested in...
The endovascular abdominal aortic aneurysm repair (EVAR) market is one of the brightest growth opportunities in the medical device arena today. As a result, the competitive landscape is heating up as several new entrants stake their claim for a share of this $1+ billion opportunity.
Killing the 2.3% excise tax on U.S. device sales before it takes effect in January would be a major victory for the industry, but with opposition from the Senate and White House, achieving repeal remains a steep climb at best.
Firm is stopping sales of four of its vaginal mesh products in the face of over 1,000 product liability lawsuits and FDA requirements for post-market safety and efficacy studies.